Combining Medication Adherence Support Plus Long-Acting Injectable Antipsychotic Medication: A Post-Hoc Analysis of 3 Pilot Studies

Name: Combining Medication Adherence Support Plus Long-Acting Injectable Antipsychotic Medication: A Post-Hoc Analysis of 3 Pilot Studies
SKU: 25308
Price: 30.00 USD
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 52 No. 3 Articles 2022 Tags: antipsychotic-agents, bipolar-disorder, Danette Conklin, Jennifer B. Levin, Kaylee Sarna, martha-sajatovic, medication adherence, psychosocial intervention, psychotic-disorders, Samuel Rodman, schizophrenia, Thomas Canales

Description

Description

Evidence-Based Psychiatry

Combining Medication Adherence Support Plus Long-Acting Injectable Antipsychotic Medication: A Post-Hoc Analysis of 3 Pilot Studies

By Thomas Canales, Samuel Rodman, Danette Conklin, Kaylee Sarna, Martha Sajatovic, Jennifer B. Levin

Combining Medication Adherence Support Plus Long-Acting Injectable Antipsychotic Medication: A Post-Hoc Analysis of 3 Pilot Studies

Description

Evidence-Based Psychiatry

Vicki L. Ellingrod, PharmD, BCPP: Leptin and Leptin Receptor Gene Polymorphisms and Increases in Body Mass Index (BMI) from Olanzapine Treatment in Persons with Schizophrenia

Agomelatine for Depression in Schizophrenia by Jochen Mutschler

Johannes Hamann, MD: How Long do Psychiatrists Wait for Response Before They Switch to Another Antipsychotic?

Gender and Schizophrenia

Combining Medication Adherence Support Plus Long-Acting Injectable Antipsychotic Medication: A Post-Hoc Analysis of 3 Pilot Studies

Description

Evidence-Based Psychiatry

Related products

Vicki L. Ellingrod, PharmD, BCPP: Leptin and Leptin Receptor Gene Polymorphisms and Increases in Body Mass Index (BMI) from Olanzapine Treatment in Persons with Schizophrenia

Agomelatine for Depression in Schizophrenia by Jochen Mutschler

Johannes Hamann, MD: How Long do Psychiatrists Wait for Response Before They Switch to Another Antipsychotic?

Gender and Schizophrenia